Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus

Novartis Pharmaceuticals · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
carslesystemiclupuserythematosus
systemic lupus erythematosus, lupus nephritis, car-t, ytb323, lupus, sle, ln, severe refractory sle, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 906398
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.